Tag: interferon

Study shows that alemtuzumab is more effective than interferon in reducing disease activity in relapsing remitting MS

New evidence that exercise could reduce patients’ blood interferon level and fatigue

Study shows that switching to natalizumab is more effective than switching to fingolimod

Researchers found a lower risk of disability progression at the 10-year follow-up in the RRMS group compared with historical cohorts

Switching patients with relapsing-remitting MS from interferon to glatiramer acetateis associated with positive treatment outcomes